222 related articles for article (PubMed ID: 9888451)
21. [Uveitis in children: about 20 cases].
Laghmari M; Karim A; Guedira K; Ibrahimy W; Dahreddine M; Essakalli NH; Mohcine Z
J Fr Ophtalmol; 2003 Jun; 26(6):609-13. PubMed ID: 12910201
[TBL] [Abstract][Full Text] [Related]
22. High mobility group box 1 (HMGB1) and macrophage migration inhibitory factor (MIF) in Kawasaki disease.
Hoshina T; Kusuhara K; Ikeda K; Mizuno Y; Saito M; Hara T
Scand J Rheumatol; 2008; 37(6):445-9. PubMed ID: 18720262
[TBL] [Abstract][Full Text] [Related]
23. [Serum adenosine deaminase and angiotensin converting enzyme activity in patients with endogenous uveitis].
Fukami R; Ohba S; Ishida K; Nakamura S; Konno M; Ohno S
Nippon Ganka Gakkai Zasshi; 1994 Mar; 98(3):287-92. PubMed ID: 8154388
[TBL] [Abstract][Full Text] [Related]
24. [Non-infectious systemic diseases and uveitis].
Díaz-Valle D; Méndez R; Arriola P; Cuiña R; Ariño M
An Sist Sanit Navar; 2008; 31 Suppl 3():97-110. PubMed ID: 19169298
[TBL] [Abstract][Full Text] [Related]
25. [Investigations of interferon and oligo-2',5'-adenylate systems in endogenous uveitis].
Kotake S
Hokkaido Igaku Zasshi; 1988 May; 63(3):398-406. PubMed ID: 2455682
[TBL] [Abstract][Full Text] [Related]
26. Macrophage migration inhibitory factor upregulates angiogenic factors and correlates with clinical measures in rheumatoid arthritis.
Kim HR; Park MK; Cho ML; Yoon CH; Lee SH; Park SH; Leng L; Bucala R; Kang I; Choe J; Kim HY
J Rheumatol; 2007 May; 34(5):927-36. PubMed ID: 17407222
[TBL] [Abstract][Full Text] [Related]
27. Decrease in the glyceraldehyde derived advanced glycation end products in the sera of patients with Vogt-Koyanagi-Harada disease.
Kitamura M; Kitaichi N; Takeuchi M; Kitamei H; Namba K; Yamagishi SI; Iwabuchi K; Onoé K; Ohno S
Br J Ophthalmol; 2005 Nov; 89(11):1407-9. PubMed ID: 16234440
[TBL] [Abstract][Full Text] [Related]
28. Macrophage migration inhibitory factor (MIF) seems crucially involved in Guillain-Barré syndrome and experimental allergic neuritis.
Nicoletti F; Créange A; Orlikowski D; Bolgert F; Mangano K; Metz C; Di Marco R; Al Abed Y
J Neuroimmunol; 2005 Nov; 168(1-2):168-74. PubMed ID: 16171874
[TBL] [Abstract][Full Text] [Related]
29. Up-regulation of macrophage migration inhibitory factor in infants with acute neonatal necrotizing enterocolitis.
Ren Y; Lin CL; Li Z; Chen XY; Huang X; Lui V; Nicholls J; Lan HY; Tam PK
Histopathology; 2005 Jun; 46(6):659-67. PubMed ID: 15910597
[TBL] [Abstract][Full Text] [Related]
30. Serum macrophage migration inhibitory factor (MIF) levels after allogeneic hematopoietic stem cell transplantation.
Toubai T; Shono Y; Nishihira J; Ibata M; Suigita J; Kato N; Ohkawara T; Tone S; Lowler KP; Ota S; Tanaka J; Asaka M; Reddy P; Imamura M
Int J Lab Hematol; 2009 Apr; 31(2):161-8. PubMed ID: 18081874
[TBL] [Abstract][Full Text] [Related]
31. Increased serum level of interleukin-33 in Vogt-Koyanagi-Harada correlates with disease activity.
Qian Y; Yu R; Zhao C; Gao F; Zhang M
Clin Immunol; 2021 Oct; 231():108846. PubMed ID: 34478883
[TBL] [Abstract][Full Text] [Related]
32. Levels of soluble E-selectin in patients with active Behcet's disease.
Sari RA; Kiziltunç A; Taysi S; Akdemir S; Gündoğdu M
Clin Rheumatol; 2005 Feb; 24(1):55-9. PubMed ID: 15338451
[TBL] [Abstract][Full Text] [Related]
33. Elevated levels of macrophage migration inhibitory factor in the peripheral blood of women with endometriosis.
Morin M; Bellehumeur C; Therriault MJ; Metz C; Maheux R; Akoum A
Fertil Steril; 2005 Apr; 83(4):865-72. PubMed ID: 15820792
[TBL] [Abstract][Full Text] [Related]
34. [Relationship between macrophage migration inhibitory factor and cardiac function in patients with congestive heart failure].
Liu Y; Yu XY; Lin QX; Yang M; Shan ZX; Zheng M
Di Yi Jun Yi Da Xue Xue Bao; 2003 Nov; 23(11):1169-70. PubMed ID: 14625178
[TBL] [Abstract][Full Text] [Related]
35. Amelioration of experimental autoimmune uveoretinitis by inhibition of glyceraldehyde-derived advanced glycation end-product formation.
Dong Z; Iwata D; Kitaichi N; Takeuchi M; Sato M; Endo N; Iwabuchi K; Ando R; Fukuhara J; Kinoshita S; Lennikov A; Kitamura M; Mizuuchi K; Kanda A; Noda K; Namba K; Yamagishi S; Ohno S; Ishida S
J Leukoc Biol; 2014 Dec; 96(6):1077-85. PubMed ID: 25201803
[TBL] [Abstract][Full Text] [Related]
36. The presence of macrophage migration inhibitory factor in human trabecular meshwork and its upregulatory effects on the T helper 1 cytokine.
Takase H; Sugita S; Rhee DJ; Imai Y; Taguchi C; Sugamoto Y; Tagawa Y; Nishihira J; Russell P; Mochizuki M
Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2691-6. PubMed ID: 12147604
[TBL] [Abstract][Full Text] [Related]
37. Down-regulation of IFN-gamma-producing CD56+ T cells after combined low-dose cyclosporine/prednisone treatment in patients with Behçet's uveitis.
Ahn JK; Seo JM; Yu J; Oh FS; Chung H; Yu HG
Invest Ophthalmol Vis Sci; 2005 Jul; 46(7):2458-64. PubMed ID: 15980236
[TBL] [Abstract][Full Text] [Related]
38. Trauma patients with positive cultures have higher levels of circulating macrophage migration inhibitory factor (MIF).
Joshi PC; Poole GV; Sachdev V; Zhou X; Jones Q
Res Commun Mol Pathol Pharmacol; 2000; 107(1-2):13-20. PubMed ID: 11334363
[TBL] [Abstract][Full Text] [Related]
39. Urine macrophage migration inhibitory factor reflects the severity of renal injury in human glomerulonephritis.
Brown FG; Nikolic-Paterson DJ; Hill PA; Isbel NM; Dowling J; Metz CM; Atkins RC
J Am Soc Nephrol; 2002 Jan; 13 Suppl 1():S7-13. PubMed ID: 11792756
[TBL] [Abstract][Full Text] [Related]
40. [Measurement of retinal circulation in uveitis of Behçet's and Harada's disease].
Sugihara I
Nippon Ganka Gakkai Zasshi; 1989 Jun; 93(6):705-13. PubMed ID: 2816579
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
